{"transactions":[{"id":4494105,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":179771,"kind":"person","name":"Morrissey David V","position":1,"cik":"0001670998","reported_name":"Morrissey David V","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Platform & Delivery Tech"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-10T20:11:12.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 6, 2017 with respect to 30,000 shares of Common Stock, with 25% vesting on January 6, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":30000,"derivative":{"exercise_price":13.88,"expiration_date":"2027-01-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-003291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670998/000120919117003291/doc4.xml","form_type":"4"}}]}